---
document_datetime: 2025-12-02 06:32:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/ariclaim.html
document_name: ariclaim.html
version: success
processing_time: 0.1120314
conversion_datetime: 2025-12-28 09:44:29.365697
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Ariclaim

[RSS](/en/individual-human-medicine.xml/67139)

##### Withdrawn

This medicine's authorisation has been withdrawn

duloxetine Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Ariclaim](#news-on)
- [More information on Ariclaim](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 9 July 2018, the European Commission withdrew the marketing authorisation for Ariclaim (duloxetine) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Eli Lilly Nederland B.V., which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Ariclaim was originally granted marketing authorisation in the EU on 11 August 2004 for treatment of stress urinary incontinence (SUI) and diabetic peripheral neuropathic pain. The marketing authorisation was initially valid for a 5-year period. It was renewed with unlimited validity in 2009 for the treatment of diabetic peripheral neuropathic pain but Ariclaim is no longer marketed in any EU country.

Ariclaim is identical to Cymbalta, Duloxetine Lilly and Xeristar, which are also authorised in the EU to treat diabetic peripheral neuropathic pain. The marketing authorisation holder will maintain the marketing authorisation for Cymbalta, Duloxetine Lilly and Xeristar.

The European Public Assessment Report (EPAR) for Ariclaim is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Ariclaim : EPAR - Summary for the public

English (EN) (472.53 KB - PDF)

**First published:** 16/07/2009

**Last updated:** 07/08/2018

[View](/en/documents/overview/ariclaim-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-745)

български (BG) (672.16 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/bg/documents/overview/ariclaim-epar-summary-public_bg.pdf)

español (ES) (504.15 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/es/documents/overview/ariclaim-epar-summary-public_es.pdf)

čeština (CS) (644.44 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/cs/documents/overview/ariclaim-epar-summary-public_cs.pdf)

dansk (DA) (503.28 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/da/documents/overview/ariclaim-epar-summary-public_da.pdf)

Deutsch (DE) (504.5 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/de/documents/overview/ariclaim-epar-summary-public_de.pdf)

eesti keel (ET) (502.82 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/et/documents/overview/ariclaim-epar-summary-public_et.pdf)

ελληνικά (EL) (698.35 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/el/documents/overview/ariclaim-epar-summary-public_el.pdf)

français (FR) (503.91 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/fr/documents/overview/ariclaim-epar-summary-public_fr.pdf)

italiano (IT) (502.08 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/it/documents/overview/ariclaim-epar-summary-public_it.pdf)

latviešu valoda (LV) (648.31 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/lv/documents/overview/ariclaim-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (615.73 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/lt/documents/overview/ariclaim-epar-summary-public_lt.pdf)

magyar (HU) (633.73 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/hu/documents/overview/ariclaim-epar-summary-public_hu.pdf)

Malti (MT) (648.72 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/mt/documents/overview/ariclaim-epar-summary-public_mt.pdf)

Nederlands (NL) (503.07 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/nl/documents/overview/ariclaim-epar-summary-public_nl.pdf)

polski (PL) (652.38 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/pl/documents/overview/ariclaim-epar-summary-public_pl.pdf)

português (PT) (503.42 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/pt/documents/overview/ariclaim-epar-summary-public_pt.pdf)

română (RO) (629.22 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/ro/documents/overview/ariclaim-epar-summary-public_ro.pdf)

slovenčina (SK) (640.41 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sk/documents/overview/ariclaim-epar-summary-public_sk.pdf)

slovenščina (SL) (600.19 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sl/documents/overview/ariclaim-epar-summary-public_sl.pdf)

Suomi (FI) (502.95 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/fi/documents/overview/ariclaim-epar-summary-public_fi.pdf)

svenska (SV) (502.79 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sv/documents/overview/ariclaim-epar-summary-public_sv.pdf)

## Product information

Ariclaim : EPAR - Product Information

English (EN) (1.04 MB - PDF)

**First published:** 16/07/2009

**Last updated:** 07/08/2018

[View](/en/documents/product-information/ariclaim-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-690)

български (BG) (2.31 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/bg/documents/product-information/ariclaim-epar-product-information_bg.pdf)

español (ES) (1.01 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/es/documents/product-information/ariclaim-epar-product-information_es.pdf)

čeština (CS) (1.74 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/cs/documents/product-information/ariclaim-epar-product-information_cs.pdf)

dansk (DA) (1.02 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/da/documents/product-information/ariclaim-epar-product-information_da.pdf)

Deutsch (DE) (1.05 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/de/documents/product-information/ariclaim-epar-product-information_de.pdf)

eesti keel (ET) (1.12 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/et/documents/product-information/ariclaim-epar-product-information_et.pdf)

ελληνικά (EL) (2.24 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/el/documents/product-information/ariclaim-epar-product-information_el.pdf)

français (FR) (1.13 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/fr/documents/product-information/ariclaim-epar-product-information_fr.pdf)

hrvatski (HR) (1.19 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/hr/documents/product-information/ariclaim-epar-product-information_hr.pdf)

íslenska (IS) (1.05 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/is/documents/product-information/ariclaim-epar-product-information_is.pdf)

italiano (IT) (1.11 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/it/documents/product-information/ariclaim-epar-product-information_it.pdf)

latviešu valoda (LV) (1.84 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/lv/documents/product-information/ariclaim-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.23 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/lt/documents/product-information/ariclaim-epar-product-information_lt.pdf)

magyar (HU) (1.78 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/hu/documents/product-information/ariclaim-epar-product-information_hu.pdf)

Malti (MT) (1.91 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/mt/documents/product-information/ariclaim-epar-product-information_mt.pdf)

Nederlands (NL) (346.3 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/nl/documents/product-information/ariclaim-epar-product-information_nl.pdf)

norsk (NO) (1.05 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/no/documents/product-information/ariclaim-epar-product-information_no.pdf)

polski (PL) (1.85 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/pl/documents/product-information/ariclaim-epar-product-information_pl.pdf)

português (PT) (1.06 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/pt/documents/product-information/ariclaim-epar-product-information_pt.pdf)

română (RO) (1.28 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/ro/documents/product-information/ariclaim-epar-product-information_ro.pdf)

slovenčina (SK) (1.79 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sk/documents/product-information/ariclaim-epar-product-information_sk.pdf)

slovenščina (SL) (1.74 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sl/documents/product-information/ariclaim-epar-product-information_sl.pdf)

Suomi (FI) (1.07 MB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/fi/documents/product-information/ariclaim-epar-product-information_fi.pdf)

svenska (SV) (988.18 KB - PDF)

**First published:**

16/07/2009

**Last updated:**

07/08/2018

[View](/sv/documents/product-information/ariclaim-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0066 09/12/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Ariclaim : EPAR - All Authorised presentations

English (EN) (468.01 KB - PDF)

**First published:** 13/07/2009

**Last updated:** 07/08/2018

[View](/en/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-828)

български (BG) (575.9 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/bg/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_bg.pdf)

español (ES) (473.56 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/es/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_es.pdf)

čeština (CS) (487.31 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/cs/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (471.7 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/da/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (468.29 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/de/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (468.45 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/et/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (509.96 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/el/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_el.pdf)

français (FR) (468.79 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/fr/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (514.12 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/hr/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (468.32 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/is/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_is.pdf)

italiano (IT) (469.17 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/it/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (501.29 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/lv/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (484.3 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/lt/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (491.1 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/hu/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (498.63 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/mt/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (468.56 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/nl/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (475.05 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/no/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_no.pdf)

polski (PL) (494.14 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/pl/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_pl.pdf)

português (PT) (480.46 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/pt/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_pt.pdf)

română (RO) (483.5 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/ro/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (487.94 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/sk/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (489.62 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/sl/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (498.63 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/fi/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (466.51 KB - PDF)

**First published:**

13/07/2009

**Last updated:**

07/08/2018

[View](/sv/documents/all-authorised-presentations/ariclaim-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Ariclaim Active substance duloxetine International non-proprietary name (INN) or common name duloxetine Therapeutic area (MeSH) Diabetic Neuropathies Anatomical therapeutic chemical (ATC) code N06AX21

### Pharmacotherapeutic group

Psychoanaleptics

### Therapeutic indication

Treatment of diabetic peripheral neuropathic pain.

Ariclaim is indicated in adults.

## Authorisation details

EMA product number EMEA/H/C/000552 Marketing authorisation holder

Eli Lilly Nederland B.V.

Papendorpseweg 83

Marketing authorisation issued 11/08/2004 Withdrawal of marketing authorisation 09/07/2018 Revision 26

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Ariclaim : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (852.44 KB - PDF)

**First published:** 16/07/2009

**Last updated:** 07/08/2018

[View](/en/documents/procedural-steps-after/ariclaim-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Ariclaim-H-C-PSUSA-00001187-201408 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/PRAC/154100/2015

English (EN) (527.52 KB - PDF)

**First published:** 30/07/2015

**Last updated:** 07/08/2018

[View](/en/documents/scientific-conclusion/ariclaim-h-c-psusa-00001187-201408-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Ariclaim-H-C-552-P46-0039 : EPAR - Assessment Report

Adopted

Reference Number: EMA/121591/2013

English (EN) (2.87 MB - PDF)

**First published:** 08/03/2013

**Last updated:** 07/08/2018

[View](/en/documents/variation-report/ariclaim-h-c-552-p46-0039-epar-assessment-report_en.pdf)

Ariclaim-H-C-552-P46-0034: EPAR - Assessment Report

Reference Number: EMA/18171/2013

English (EN) (1006.65 KB - PDF)

**First published:** 17/01/2013

**Last updated:** 07/08/2018

[View](/en/documents/variation-report/ariclaim-h-c-552-p46-0034-epar-assessment-report_en.pdf)

Ariclaim-H-C-552-WS-0076 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/285264/2012

English (EN) (2 MB - PDF)

**First published:** 13/06/2012

**Last updated:** 07/08/2018

[View](/en/documents/variation-report/ariclaim-h-c-552-ws-0076-epar-assessment-report-variation_en.pdf)

Ariclaim-H-C-552-II-0024 : EPAR - Scientific Discussion - Variation

Adopted

English (EN) (609.94 KB - PDF)

**First published:** 25/02/2008

**Last updated:** 07/08/2018

[View](/en/documents/scientific-discussion-variation/ariclaim-h-c-552-ii-0024-epar-scientific-discussion-variation_en.pdf)

Ariclaim-H-552-A18-652 : EPAR - Scientific Conclusion

Adopted

English (EN) (582.14 KB - PDF)

**First published:** 07/02/2006

**Last updated:** 07/08/2018

[View](/en/documents/scientific-conclusion/ariclaim-h-552-a18-652-epar-scientific-conclusion_en.pdf)

## Initial marketing authorisation documents

Ariclaim : EPAR - Scientific Discussion

English (EN) (1.1 MB - PDF)

**First published:** 07/02/2006

**Last updated:** 07/08/2018

[View](/en/documents/scientific-discussion/ariclaim-epar-scientific-discussion_en.pdf)

Ariclaim : EPAR - Procedural steps taken before authorisation

English (EN) (552.62 KB - PDF)

**First published:** 07/02/2006

**Last updated:** 07/08/2018

[View](/en/documents/procedural-steps/ariclaim-epar-procedural-steps-taken-authorisation_en.pdf)

#### News on Ariclaim

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 November 2011](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-november-2011) 18/11/2011

#### More information on Ariclaim

- [EMEA-000420-PIP01-10 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000420-pip01-10)
- [Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Duloxetine (F1J-MC-B059) - post-authorisation study](https://catalogues.ema.europa.eu/study/44527)
- [Stress Urinary Incontinence and Suicidality Seen in the United Kingdom General Practice Research Database (F1J-MC-B056) - post-authorisation study](https://catalogues.ema.europa.eu/study/21190)

**This page was last updated on** 07/08/2018

## Share this page

[Back to top](#main-content)